|
Getting your Trinity Audio player ready...
|
Summary
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert regarding the circulation of fake POSTINOR-2 emergency contraceptive pills. The agency confirmed the medicine to be unapproved by the Society for Family Health.
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent public alert regarding the circulation of falsified batches of POSTINOR 2 (Levonorgestrel 0.75mg), a crucial emergency contraceptive pill.
In a public health alert released on their official X handle on August 26, 2025, the National Agency for Food and Drug Administration and Control (NAFDAC) stated a report was received from the Marketing Authorisation Holder Society for Family Health (SFH) confirming that they did not import the product batch in question.
NAFDAC provided clear distinctions to help identify the counterfeit products, “Product details:
•On the fake product, the PIN verification sticker has a smaller font size and misspells “Verify” as “Veify”. The original sticker uses a larger, clearer font.
•On the fake pack, the word “Distributed in Nigeria” is wrongly spelt as “Distnibuted in Nigeria.”
NAFDAC also stated that the falsified Postinor-2 poses serious risks to individual health and public safety due to the possible presence of harmful or substandard ingredients, incorrect dosages of levonorgestrel, and unsafe manufacturing practices.
“These risks include contraceptive failure, toxic contamination, unpredictable side effects, delayed or missed access to genuine emergency contraception, and long-term reproductive health complications,” the alert reads.
According to NAFDAC, counterfeit medicines can contain unknown substances that may cause allergic reactions, organ damage, or even death. They strongly advise patients to obtain Postinor-2 only from verified pharmacies or licensed healthcare providers.
NAFDAC urged both healthcare professionals and consumers to report any suspected sale of fake or substandard medicines and medical devices.
